4//SEC Filing
MCGAULEY THOMAS 4
Accession 0001550701-25-000002
CIK 0000034956other
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 7:01 PM ET
Size
9.0 KB
Accession
0001550701-25-000002
Insider Transaction Report
Form 4
MCGAULEY THOMAS
Interim CFO
Transactions
- Purchase
Common Stock
2025-11-17$7.34/sh+2,000$14,674→ 2,000 total - Purchase
Common Stock
2025-11-17$7.23/sh+5,000$36,140→ 5,000 total(indirect: By Spouse) - Purchase
Common Stock
2025-11-17$7.35/sh+1,000$7,350→ 1,000 total(indirect: By Children)
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices ranging from $7.14 to $7.43. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- [F2]This transaction was executed in multiple trades at prices ranging from $7.17 to $7.30. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
Documents
Issuer
TENAX THERAPEUTICS, INC.
CIK 0000034956
Entity typeother
Related Parties
1- filerCIK 0001550701
Filing Metadata
- Form type
- 4
- Filed
- Nov 18, 7:00 PM ET
- Accepted
- Nov 19, 7:01 PM ET
- Size
- 9.0 KB